Among the 30,420 participants involved in the Moderna vaccine study, 196 became ill with Covid symptoms but, of these, only 11 were part of the vaccinated group, while 185 received placebo. Confirming for the mRNA-1273 vaccine an efficacy of 94.1% in preventing symptomatic Covid-19 and 100% against severe forms, is the publication of the results of the Phase 3 Cove study in the famous peer review journal New England Journal of Medicine. The data had been announced by the company in late November.
The Moderna vaccine is 94.1% effective and 100% effective in severe forms
2020-12-31T11:01:51.608Z
Confirming for the mRNA-1273 vaccine 94.1% efficacy in preventing symptomatic Covid-19 and 100% against severe forms, is the publication of the results of the Phase 3 Cove study in the New England Journal of Medicine ( HANDLE)
